Your browser doesn't support javascript.
loading
Loss of Neural Automaticity Contributes to Slower Walking in COPD Patients.
Hassan, S Ahmed; Bonetti, Leandro Viçosa; Kasawara, Karina Tamy; Stanbrook, Matthew B; Rozenberg, Dmitry; Reid, W Darlene.
Afiliação
  • Hassan SA; Physical Therapy, Temerty Faculty of Medicine, University of Toronto, Ontario, ON M5G 1V7, Canada.
  • Bonetti LV; Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, ON M5T 3M6, Canada.
  • Kasawara KT; Department of Physical Therapy, Universidade de Caxias do Sul, Caxias do Sul 95070-560, Rio Grande do Sul, Brazil.
  • Stanbrook MB; Post-Graduation Program in Health Sciences, Universidade de Caxias do Sul, Caxias do Sul 95070-560, Rio Grande do Sul, Brazil.
  • Rozenberg D; Physical Therapy, Temerty Faculty of Medicine, University of Toronto, Ontario, ON M5G 1V7, Canada.
  • Reid WD; Division of Respirology, Temerty Faculty of Medicine, University Health Network, Toronto, ON M5T 2S8, Canada.
Cells ; 11(10)2022 05 11.
Article em En | MEDLINE | ID: mdl-35626645
The physical impairments (e.g., slower walking speed) in patients with chronic obstructive pulmonary disease (COPD) have been attributed to peripheral characteristics (e.g., muscle atrophy). However, cognitive impairment may compromise motor control including walking automaticity. The objective of this study was to investigate PFC neural activity, evaluated using changes in oxygenated hemoglobin (ΔO2Hb), during preferred paced walking (PPW) in COPD patients and age-matched controls. The ΔO2Hb from the left and right dorsolateral PFC was measured using functional near-infrared spectroscopy. Fifteen COPD patients (age: 71 ± 8) and twenty age-matched controls (69 ± 7 years) participated. Two-way mixed ANOVA demonstrated that O2Hb in both groups decreased during PPW from the start (quintile 1; Q1) to the end (quintile 5; Q5) in the left dorsolateral and medial PFC. Q1 was comprised of the data during the first 20% of the task, while Q5 included data collected in the last 20% of the task duration. PPW duration ranged between 30.0 and 61.4 s in the control group and between 28.6 and 73.0 s in COPD patients. COPD patients demonstrated a higher O2Hb in Q5 compared to the negative O2Hb in controls in the right medial and dorsolateral PFC during PPW. PPW velocity was lower in COPD patients compared to controls (1.02 ± 0.22 vs. 1.22 ± 0.14 m/s, p = 0.005). Healthy older controls exhibited automaticity during walking unlike patients with COPD. The lesser decrease in O2Hb in COPD patients may be attributed to increased executive demands or affect-related cues (e.g., pain or dyspnea) during walking.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Disfunção Cognitiva Limite: Aged / Humans / Middle aged Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Disfunção Cognitiva Limite: Aged / Humans / Middle aged Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá